According to Sana Biotechnology's latest financial reports the company has $0.20 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $0.20 B | -51.6% |
2022-12-31 | $0.42 B | -23.06% |
2021-12-31 | $0.55 B | 45.66% |
2020-12-31 | $0.37 B | 172.17% |
2019-12-31 | $0.13 B | 353.74% |
2018-12-31 | $30.63 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | $0.20 B | 1.46% | ๐บ๐ธ USA |